IMMUNOCORE HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.1 USD | -0.62% |
|
+4.08% | -14.96% |
| 01:28pm | Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target | MT |
| Mar. 21 | Immunocore Holdings Files Mixed-Securities Shelf Registration | MT |
Chart calendar Immunocore Holdings plc
0b4d.Y1efHHzUL9SQz_W9DuznknTVJJI0VlQTiD41x5OF8ow.UC6oTkWYVuHi_qXRPpuf9UC5YNkGZ2VG-VYCtKbrgehWEcVZF64W7fj4mg~3f3842444c50f87f040e65e7773bfb2f
Upcoming events on Immunocore Holdings plc
Past events on Immunocore Holdings plc
| 2024-04-25 04:00 pm | Canaccord Horizons in Oncology Conference |
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-04-10 11:00 am | Needham Healthcare Conference - Fireside Chat |
| 2024-03-14 09:30 am | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 | Leerink Partners Global Biopharma Conference |
| 2024-03-05 04:30 pm | Retroviruses and Opportunistic Infections Conference - Poster No D5 |
| 2024-03-05 11:10 am | TD Cowen Health Care Conference - Fireside Chat |
| 2024-03-04 04:30 pm | Retroviruses and Opportunistic Infections Conference - Poster No D6 |
| 2024-02-28 08:00 am | Q4 2023 Earnings Call |
| 2024-02-28 07:00 am | Q4 2023 Earnings Release |
| 2024-01-10 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-27 10:30 am | BTIG Ophthalmology Day |
| 2023-11-14 05:30 am | Jefferies London Healthcare Conference |
| 2023-11-07 | Truist Securities Healthcare Conference |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-11-05 | Society for Melanoma Research Congress - Poster No: P: 163 |
| 2023-11-05 | Society for Melanoma Research Congress - Poster No: P: 089 |
| 2023-11-05 | Society for Melanoma Research Congress - Poster No: P-225 |
| 2023-11-05 | Society for Melanoma Research Congress - Poster No: P-096 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 25,7 | 30,1 26,9 12.02% | 26,5 25,7 3.18% | 144 139 3.22% | 197 196 0.38% | 230 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -82,7 -74,1 -11.68% | -130 -134 3.45% | -33,5 -4,89 -584.59% | -43,9 -43,8 -0.19% | -68,7 |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -86,2 -89,5 3.67% | -135 -137 1.38% | -39,6 -17,6 -125.47% | -47,1 -50,5 6.67% | -73,7 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -87,4 -93,1 6.15% | -141 -140 -0.81% | -44,1 -23,9 -84.39% | -48,1 -39,4 -22.14% | -63,7 |
|
Net income Million GBP | Released Forecast Spread | -104 | -74,1 -65,4 -13.28% | -132 -128 -2.83% | -41,2 -17,4 -137.3% | -43,7 -39,8 -9.69% | -71,6 |
|
EPS GBP | Released Forecast Spread | 0,00 | -2,79 -8,44 66.96% | -3,10 -2,99 -3.77% | -0,90 -0,39 -127.99% | -0,89 -0,80 -11.11% | -1,25 |
| Announcement Date | 07/05/20 | 25/03/21 | 03/03/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 6,59 5,61 17.47% | 22,5 6,47 247.63% | 32,0 17,3 84.77% | 41,2 30,3 36.08% | 48,1 44,9 6.93% | 44,5 41,3 7.73% | 47,8 46,2 3.35% | 51,5 50,6 1.68% | 55,4 53,1 4.47% | 55,0 | 56,9 | 58,2 | 60,1 | 62,8 |
|
EBITDA Million GBP | Released Forecast Spread | -36,5 -34,0 -7.4% | -14,8 -37,5 60.58% | -5,36 -31,0 82.73% | 7,65 -16,0 147.81% | -21,0 10,1 -307.81% | -16,1 3,70 -535.19% | -14,5 -21,5 32.76% | 0,67 -20,6 103.25% | -13,4 -18,0 25.46% | -15,5 | -15,7 | -17,0 | -24,9 | |
|
EBIT Million GBP | Released Forecast Spread | -37,8 -37,6 -0.67% | -16,5 -38,9 57.68% | -6,99 -26,8 73.93% | 6,17 -17,3 135.61% | -22,3 -0,89 -2411.76% | -17,4 -14,1 -23.52% | -15,8 -16,6 4.71% | -0,70 -14,4 95.16% | -13,5 -11,6 -15.93% | -15,0 | -16,3 | -17,2 | -19,6 | -17,8 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -39,2 -37,4 -4.69% | -17,8 -40,1 55.61% | -8,27 -27,3 69.7% | 4,98 -15,2 132.78% | -23,1 -2,46 -838.09% | -16,5 -13,0 -26.76% | -13,9 -17,1 18.38% | 1,76 -14,7 111.99% | -20,3 -10,7 -88.57% | -13,6 | -15,0 | -16,2 | -18,8 | -19,4 |
|
Net income Million GBP | Released Forecast Spread | -39,4 -35,4 -11.4% | -16,1 -38,0 57.55% | -6,12 -25,9 76.37% | 6,23 -12,8 148.64% | -25,2 -1,00 -2423.25% | -16,7 -14,4 -16.02% | -14,1 -16,5 14.79% | 1,90 -14,6 113.02% | -15,6 -10,5 -48.72% | -14,0 | -15,0 | -15,8 | -17,6 | -19,0 |
|
EPS GBP | Released Forecast Spread | -0,90 -0,80 -12.17% | -0,37 -0,86 56.99% | -0,14 -0,57 75.62% | 0,12 -0,28 143.3% | -0,54 -0,02 -2267.38% | -0,35 -0,30 -17.42% | -0,29 -0,34 14.23% | 0,04 -0,30 113.52% | -0,32 -0,21 -49.07% | -0,29 | -0,29 | -0,31 | -0,33 | -0,37 |
| Announcement Date | 03/03/22 | 11/05/22 | 10/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 10/08/23 | 07/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Immunocore Holdings plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMCR Stock
- Calendar Immunocore Holdings plc
